Key facts
- This page summarizes Clay Thorp's Form 3 filing for Vigil Neuroscience, Inc. (VIGL).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 06 Jan 2022, 19:34.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
These shares of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") are convertible into Common Stock on a one-for-2.7732 basis at the option of the holder, and will automatically convert into the number of shares shown in Column 3 immediately prior to the closing of the Issuer's initial public offering. The Preferred Stock has no expiration date.
Footnote F2
The shares are held directly by Hatteras Venture Partners VI, L.P. ("Hatteras VI"). Hatteras Venture Advisors VI, LLC ("HVA VI") is the general partner of Hatteras VI. The Reporting Person is a managing member of HVA VI and disclaims beneficial ownership of the shares held by Hatteras VI except to the extent of his pecuniary interest therein, if any.
SEC remarks
Exhibit 24 - Power of Attorney